Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer/testis antigens, gametogenesis and cancer.
Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Simpson AJ, et al. Among authors: jungbluth a. Nat Rev Cancer. 2005 Aug;5(8):615-25. doi: 10.1038/nrc1669. Nat Rev Cancer. 2005. PMID: 16034368 Review.
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ, Chen YT. Jungbluth AA, et al. Am J Surg Pathol. 1998 May;22(5):595-602. doi: 10.1097/00000478-199805000-00011. Am J Surg Pathol. 1998. PMID: 9591730
Melan-A is a previously defined, melanocyte differentiation antigen, and an anti-Melan-A murine monoclonal antibody, A103, was recently developed by our group. ...Of the positive cases, A103 showed homogeneous staining in a significantly higher proport …
Melan-A is a previously defined, melanocyte differentiation antigen, and an anti-Melan-A murine monoclonal antibody, A1 …
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA. Busam KJ, et al. Among authors: jungbluth aa. Am J Surg Pathol. 1998 Aug;22(8):976-82. doi: 10.1097/00000478-199808000-00007. Am J Surg Pathol. 1998. PMID: 9706977
To evaluate a potential role of A103 in the differential diagnosis of melanocytic from nonmelanocytic tumors, we also analyzed a number of benign and malignant peripheral nerve sheath tumors, fibrohistiocytic tumors, and leiomyosarcomas. ...None of the nonmelanocyti …
To evaluate a potential role of A103 in the differential diagnosis of melanocytic from nonmelanocytic tumors, we also analyzed a
Melan-A, a new melanocytic differentiation marker.
Busam KJ, Jungbluth AA. Busam KJ, et al. Among authors: jungbluth aa. Adv Anat Pathol. 1999 Jan;6(1):12-8. doi: 10.1097/00125480-199901000-00002. Adv Anat Pathol. 1999. PMID: 10197235 Review.
Melan-A/MART-1 is a recently identified new melanocytic differentiation marker, which is recognized as an antigen on melanoma cells by cytotoxic T-lymphocytes. It is of interest for clinicians as potential immunotherapeutic target and it is relevant for pathologists …
Melan-A/MART-1 is a recently identified new melanocytic differentiation marker, which is recognized as an antigen on melanoma …
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Jungbluth AA, Iversen K, Coplan K, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ. Jungbluth AA, et al. Virchows Arch. 1999 May;434(5):429-35. doi: 10.1007/s004280050362. Virchows Arch. 1999. PMID: 10389626
A characteristic finding is their reactivity with HMB-45, a monoclonal antibody to the melanocyte-associated antigen gp-100. We tested 18 angiomyolipomas for their reactivity with A103, a monoclonal antibody to Melan-A (MART-1), another melanocyte-asso
A characteristic finding is their reactivity with HMB-45, a monoclonal antibody to the melanocyte-associated antigen gp-100. W
Expression of MAGE-antigens in normal tissues and cancer.
Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, Spagnoli GC, Old LJ. Jungbluth AA, et al. Int J Cancer. 2000 Feb 15;85(4):460-5. Int J Cancer. 2000. PMID: 10699915
Because MAGE genes are silent in most normal tissues except testis but are activated in a variety of neoplastic lesions, MAGE antigens represent ideal targets for immunotherapy. ...Monoclonal antibody (MAb) 57B, originally thought to be specific for MAGE-3, but now known t …
Because MAGE genes are silent in most normal tissues except testis but are activated in a variety of neoplastic lesions, MAGE antigen …
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA. Busam KJ, et al. Among authors: jungbluth aa. Mod Pathol. 2000 Apr;13(4):459-65. doi: 10.1038/modpathol.3880078. Mod Pathol. 2000. PMID: 10786815
Because tumor-infiltrating lymphocytes in melanoma are associated with longer survival, our findings suggest a potential prognostic role for MAGE. Furthermore, the seeming restriction of immunopositivity to invasive malignant tumors suggests a potential diagnostic r …
Because tumor-infiltrating lymphocytes in melanoma are associated with longer survival, our findings suggest a potential prognostic r …
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam KJ, Old LJ. Jungbluth AA, et al. Br J Cancer. 2000 Aug;83(4):493-7. doi: 10.1054/bjoc.2000.1291. Br J Cancer. 2000. PMID: 10945497 Free PMC article.
Cancer/testis (CT) antigens such as those encoded by the MAGE-gene family are expressed in a wide variety of malignant neoplasms. ...Immunohistochemical (IHC) analysis of a normal tissue panel revealed staining solely in germ cells of testes. A series of 59 l …
Cancer/testis (CT) antigens such as those encoded by the MAGE-gene family are expressed in a wide variety of malignant neoplasms. ... …
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Jungbluth AA, et al. Int J Cancer. 2001 Jun 15;92(6):856-60. doi: 10.1002/ijc.1282. Int J Cancer. 2001. PMID: 11351307
NY-ESO-1, a member of the CT (cancer/testis) family of antigens, is expressed in normal testis and in a range of human tumor types. ...In the present study, a method for the immunochemical detection of NY-ESO-1 in paraffin-embedded tissues has been developed …
NY-ESO-1, a member of the CT (cancer/testis) family of antigens, is expressed in normal testis and in a range of human tumor t …
Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Prasad ML, et al. Among authors: jungbluth aa. Am J Surg Pathol. 2001 Jun;25(6):782-7. doi: 10.1097/00000478-200106000-00010. Am J Surg Pathol. 2001. PMID: 11395556
Immunohistochemical studies may be needed for a final diagnosis. A number of new monoclonal antibodies to melanocytic differentiation antigens have been studied recently on primary cutaneous and metastatic melanoma. ...All 44 sinonasal melanomas were positive for ty …
Immunohistochemical studies may be needed for a final diagnosis. A number of new monoclonal antibodies to melanocytic differen …
269 results
Jump to page
Feedback